fondaparinux sodium 7.5 MG per 0.6 ML Prefilled Syringe
- RxCUI
- 861365
- RxNorm name
- fondaparinux sodium 7.5 MG per 0.6 ML Prefilled Syringe
- Display name
- fondaparinux sodium 7.5 MG per 0.6 ML Prefilled Syringe
- Full name
- fondaparinux sodium 7.5 MG per 0.6 ML Prefilled Syringe
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:24
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| fondaparinux sodium | FONDAPARINUX SODIUM | Zydus Pharmaceuticals (USA) Inc. | dffbf7c9-495e-4a33-ac76-57b52f014fc2 | 2025-10-28 | Boxed warning, Warnings, Adverse reactions | 861365 |
| Fondaparinux Sodium | FONDAPARINUX SODIUM | Sandoz Inc. | baa50757-a927-4d56-a933-5d7798fe6ab0 | 2025-08-27 | Boxed warning, Warnings, Adverse reactions | 861365 |
| Arixtra | FONDAPARINUX SODIUM | Mylan Institutional LLC | d3b30c68-cf45-4b46-8ba6-72090f7ba01a | 2024-12-10 | Boxed warning, Warnings, Adverse reactions | 861365 |
| FONDAPARINUX SODIUM | FONDAPARINUX SODIUM | Eugia US LLC | 8ea61d0d-4403-4d9f-a946-85a459cc0aa0 | 2024-01-10 | Boxed warning, Warnings, Adverse reactions | 861365 |
| Fondaparinux Sodium | FONDAPARINUX SODIUM | Dr. Reddy's Laboratories Limited | 49e0d7bc-3f49-849b-c77c-98682d1c0d19 | 2021-09-10 | Boxed warning, Warnings, Adverse reactions | 861365 |
| fondaparinux sodium | FONDAPARINUX SODIUM | Italfarmaco S.p.A | 58789e3d-e5bc-4c2e-a527-495a252fcecd | 2020-10-30 | Boxed warning, Warnings, Adverse reactions | 861365 |
| Fondaparinux Sodium | FONDAPARINUX SODIUM | Mylan Institutional LLC | 4b65f642-87f7-4da5-a9c9-02cd1f8d9d16 | 2020-08-15 | Boxed warning, Warnings, Adverse reactions | 861365 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| dffbf7c9-495e-4a33-ac76-57b52f014fc2 | fondaparinux sodium 7.5 MG in 0.6 ML Prefilled Syringe [PSN] · 0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [SCD] · fondaparinux sodium 7.5 MG per 0.6 ML Prefilled Syringe [SY] | 3 | 20 | These highlights do not include all the information needed to use FONDAPARINUX SODIUM INJECTION safely and effectively. See full prescribing information for FONDAPARINUX SODIUM INJECTION. FONDAPARINUX SODIUM injection, for subcutaneous use Initial U.S. Approval: 2001 | 20251028 |
| baa50757-a927-4d56-a933-5d7798fe6ab0 | fondaparinux sodium 7.5 MG in 0.6 ML Prefilled Syringe [PSN] · 0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [SCD] · fondaparinux sodium 7.5 MG per 0.6 ML Prefilled Syringe [SY] | 3 | 18 | These highlights do not include all the information needed to use FONDAPARINUX SODIUM INJECTION safely and effectively. See full prescribing information for FONDAPARINUX SODIUM INJECTION. FONDAPARINUX SODIUM injection, for subcutaneous use Initial U.S. Approval: 2001 | 20250827 |
| 49e0d7bc-3f49-849b-c77c-98682d1c0d19 | fondaparinux sodium 7.5 MG in 0.6 ML Prefilled Syringe [PSN] · 0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [SCD] · fondaparinux sodium 7.5 MG per 0.6 ML Prefilled Syringe [SY] | 3 | 16 | These highlights do not include all the information needed to use FONDAPARINUX SODIUM INJECTION safely and effectively. See full prescribing information for FONDAPARINUX SODIUM INJECTION. FONDAPARINUX SODIUM injection for subcutaneous use Initial U.S. Approval: 2001 | 20210910 |
| d3b30c68-cf45-4b46-8ba6-72090f7ba01a | fondaparinux sodium 7.5 MG in 0.6 ML Prefilled Syringe [PSN] · 0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [SCD] · fondaparinux sodium 7.5 MG per 0.6 ML Prefilled Syringe [SY] | 3 | 13 | These highlights do not include all the information needed to use ARIXTRA safely and effectively. See full prescribing information for ARIXTRA. ARIXTRA (fondaparinux sodium injection), for subcutaneous use Initial U.S. Approval: 2001 | 20241210 |
| 58789e3d-e5bc-4c2e-a527-495a252fcecd | fondaparinux sodium 7.5 MG in 0.6 ML Prefilled Syringe [PSN] · 0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [SCD] · fondaparinux sodium 7.5 MG per 0.6 ML Prefilled Syringe [SY] | 3 | 11 | These highlights do not include all the information needed to use FONDAPARINUX SODIUM INJECTION safely and effectively. See full prescribing information for FONDAPARINUX SODIUM INJECTION. FONDAPARINUX SODIUM injection, for subcutaneous use Initial U.S. Approval: 2001 | 20201030 |
| 4b65f642-87f7-4da5-a9c9-02cd1f8d9d16 | fondaparinux sodium 7.5 MG in 0.6 ML Prefilled Syringe [PSN] · 0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [SCD] · fondaparinux sodium 7.5 MG per 0.6 ML Prefilled Syringe [SY] | 3 | 11 | These highlights do not include all the information needed to use FONDAPARINUX SODIUM INJECTION safely and effectively. See full prescribing information for FONDAPARINUX SODIUM INJECTION. FONDAPARINUX SODIUM injection, for subcutaneous use Initial U.S. Approval: 2001 | 20200815 |
| 8ea61d0d-4403-4d9f-a946-85a459cc0aa0 | fondaparinux sodium 7.5 MG in 0.6 ML Prefilled Syringe [PSN] · 0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [SCD] · fondaparinux sodium 7.5 MG per 0.6 ML Prefilled Syringe [SY] | 3 | 5 | These highlights do not include all the information needed to use FONDAPARINUX SODIUM INJECTION safely and effectively. See full prescribing information for FONDAPARINUX SODIUM INJECTION. FONDAPARINUX SODIUM injection, for subcutaneous use Initial U.S. Approval: 2001 | 20240110 |
| ec235119-cb58-4939-942c-11d3923d289f | fondaparinux sodium 7.5 MG in 0.6 ML Prefilled Syringe [PSN] · 0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [SCD] · fondaparinux sodium 7.5 MG per 0.6 ML Prefilled Syringe [SY] | 3 | 1 | These highlights do not include all the information needed to use ARIXTRA safely and effectively. See full prescribing information for ARIXTRA. ARIXTRA (fondaparinux sodium) Solution for subcutaneous injection Initial U.S. Approval: 2001 | 20120123 |